COVID-19 Serological Tests: How Well Do They Actually Perform?
Tóm tắt
In only a few months after initial discovery in Wuhan, China, SARS-CoV-2 and the associated coronavirus disease 2019 (COVID-19) have become a global pandemic causing significant mortality and morbidity and implementation of strict isolation measures. In the absence of vaccines and effective therapeutics, reliable serological testing must be a key element of public health policy to control further spread of the disease and gradually remove quarantine measures. Serological diagnostic tests are being increasingly used to provide a broader understanding of COVID-19 incidence and to assess immunity status in the population. However, there are discrepancies between claimed and actual performance data for serological diagnostic tests on the market. In this study, we conducted a review of independent studies evaluating the performance of SARS-CoV-2 serological tests. We found significant variability in the accuracy of marketed tests and highlight several lab-based and point-of-care rapid serological tests with high levels of performance. The findings of this review highlight the need for ongoing independent evaluations of commercialized COVID-19 diagnostic tests.
Từ khóa
Tài liệu tham khảo
Zhu, 2020, A Novel Coronavirus from Patients with Pneumonia in China, 2019, N. Engl. J. Med., 382, 727, 10.1056/NEJMoa2001017
Zhou, 2020, A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature, 579, 270, 10.1038/s41586-020-2012-7
Lu, 2020, Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding, Lancet, 395, 565, 10.1016/S0140-6736(20)30251-8
(2020, May 27). World Health Organization COVID-19 Situation Report 127. Available online: https://www.who.int/docs/default-source/coronaviruse/situation-reports.
Wang, 2020, Remdesivir in adults with severe COVID-19: A randomised, double-blind, placebo-controlled, multicentre trial, Lancet, 395, 1569, 10.1016/S0140-6736(20)31022-9
Grein, 2020, Compassionate Use of Remdesivir for Patients with Severe Covid-19, N. Engl. J. Med., 382, 2327, 10.1056/NEJMoa2007016
Li, 2020, Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2), Science, 368, 489, 10.1126/science.abb3221
Bai, Y., Yao, L., Wei, T., Tian, F., Jin, D.Y., Chen, L., and Wang, M. (2020). Presumed Asymptomatic Carrier Transmission of COVID-19. JAMA.
Winter, A.K., and Hegde, S.T. (2020). The important role of serology for COVID-19 control. Lancet Infect. Dis.
Janeway, C.A. (2001). Immunobiology, 5th edition: The Immune System in Health and Disease, Garland Publishing.
Azkur, A.K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Bruggen, M.C., O’Mahony, L., Gao, Y., Nadeau, K., and Akdis, C.A. (2020). Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Allergy.
Yu, H.Q., Sun, B.Q., Fang, Z.F., Zhao, J.C., Liu, X.Y., Li, Y.M., Sun, X.Z., Liang, H.F., Zhong, B., and Huang, Z.F. (2020). Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients. Eur. Respir. J.
Cong, Y., Ulasli, M., Schepers, H., Mauthe, M., V’Kovski, P., Kriegenburg, F., Thiel, V., de Haan, C.A.M., and Reggiori, F. (2020). Nucleocapsid Protein Recruitment to Replication-Transcription Complexes Plays a Crucial Role in Coronaviral Life Cycle. J. Virol., 94.
Ni, L., Ye, F., Cheng, M.L., Feng, Y., Deng, Y.Q., Zhao, H., Wei, P., Ge, J., Gou, M., and Li, X. (2020). Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals. Immunity.
Jiang, S., Hillyer, C., and Du, L. (2020). Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses: (Trends in Immunology 41, 355-359; 2020). Trends Immunol.
Vashist, S.K. (2020). In Vitro Diagnostic Assays for COVID-19: Recent Advances and Emerging Trends. Diagnostics, 10.
Yan, Y., Chang, L., and Wang, L. (2020). Laboratory testing of SARS-CoV, MERS-CoV, and SARS-CoV-2 (2019-nCoV): Current status, challenges, and countermeasures. Rev. Med. Virol.
To, 2020, Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: An observational cohort study, Lancet Infect. Dis., 20, 565, 10.1016/S1473-3099(20)30196-1
Wolfel, R., Corman, V.M., Guggemos, W., Seilmaier, M., Zange, S., Muller, M.A., Niemeyer, D., Jones, T.C., Vollmar, P., and Rothe, C. (2020). Virological assessment of hospitalized patients with COVID-2019. Nature.
Guo, L., Ren, L., Yang, S., Xiao, M., Chang, D., Yang, F., Dela Cruz, C.S., Wang, Y., Wu, C., and Xiao, Y. (2020). Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19). Clin. Infect. Dis.
Tan, W.L.Y., and Zhang, J. (2020). Viral Kinetics and Antibody Responses in Patients with COVID-19. medRxiv (preprint).
Mandrekar, 2010, Simple statistical measures for diagnostic accuracy assessment, J. Thorac. Oncol., 5, 763, 10.1097/JTO.0b013e3181dab122
U.S. Food & Drug Administratin (2020, June 06). Independent Evaluations of COVID-19 Serological Tests, Available online: https://open.fda.gov/apis/device/covid19serology/.
(2020, May 20). FINDDx-SARS-COV-2 DIAGNOSTICS: PERFORMANCE DATA. Available online: https://www.finddx.org/covid-19/dx-data/.
Ria Lassaunière, A.F., Harboe, Z.B., Nielsen, A.C.Y., Fomsgaard, A., Krogfelt, K.A., and Charlotte S. Jørgensen, C.S. (2020). Evaluation of nine commercial SARS-CoV-2 immunoassays. medRxiv (preprint).
Liu, W., Liu, L., Kou, G., Zheng, Y., Ding, Y., Ni, W., Wang, Q., Tan, L., Wu, W., and Tang, S. (2020). Evaluation of Nucleocapsid and Spike Protein-Based Enzyme-Linked Immunosorbent Assays for Detecting Antibodies against SARS-CoV-2. J. Clin. Microbiol., 58.
Lou, B. (2020). Serology characteristics of SARS-CoV-2 infection since the exposure and post symptoms onset. medRxiv (preprint).
Zhang, J., Li, N., Liu, Y., Ye, R., Qin, X., and Zheng, R. (2020). Serological detection of 2019-nCoV respond to the epidemic: A useful complement to nucleic acid testing. medRxiv (preprint).
Bryan, A., Pepper, G., Wener, M.H., Fink, S.L., Morishima, C., Chaudhary, A., Jerome, K.R., Mathias, P.C., and Greninger, A.L. (2020). Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho. J. Clin. Microbiol.
Weinstein, M.C., Freedberg, K.A., Hyle, E.P., and Paltiel, A.D. (2020). Waiting for Certainty on Covid-19 Antibody Tests-At What Cost?. N. Engl. J. Med.
Sood, N., Simon, P., Ebner, P., Eichner, D., Reynolds, J., Bendavid, E., and Bhattacharya, J. (2020). Seroprevalence of SARS-CoV-2-Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020. JAMA.
(2020, May 02). New York State Governor Website, Available online: https://www.governor.ny.gov/news/amid-ongoing-covid-19-pandemic-governor-cuomo-announces-results-completed-antibody-testing.
Popovich, N., and Sanger-Katz, M. (2020, June 28). The World Is Still Far From Herd Immunity for Coronavirus. Available online: https://www.nytimes.com/interactive/2020/05/28/upshot/coronavirus-herd-immunity.html.